DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CYTOSAR-U

« Back to Dashboard

All Clinical Trials for Cytosar-u

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002833	Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia	Completed	National Cancer Institute (NCI)	Phase 2	1994-10-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. Colony stimulating factors such as filgrastim may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system recover from the side effects of chemotherapy. PURPOSE: Phase II trial to study the effectiveness of peripheral stem cell transplantation plus filgrastim in treating patients who have acute or chronic myelogenous leukemia.
NCT00002833	Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia	Completed	M.D. Anderson Cancer Center	Phase 2	1994-10-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. Colony stimulating factors such as filgrastim may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system recover from the side effects of chemotherapy. PURPOSE: Phase II trial to study the effectiveness of peripheral stem cell transplantation plus filgrastim in treating patients who have acute or chronic myelogenous leukemia.
NCT00002835	Combination Chemotherapy in Treating Patients With Lymphoma	Completed	National Cancer Institute (NCI)	Phase 3	1995-07-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of combination chemotherapy in treating patients who have intermediate-grade or immunoblastic lymphoma.
NCT00002835	Combination Chemotherapy in Treating Patients With Lymphoma	Completed	M.D. Anderson Cancer Center	Phase 3	1995-07-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of combination chemotherapy in treating patients who have intermediate-grade or immunoblastic lymphoma.

Clinical Trial Conditions for Cytosar-u

Condition Name

Condition Name for Cytosar-u
Intervention	Trials
Acute Myeloid Leukemia	16
Refractory Acute Myeloid Leukemia	12
Leukemia	11
Recurrent Acute Myeloid Leukemia	11

Condition MeSH

Condition MeSH for Cytosar-u
Intervention	Trials
Leukemia	52
Leukemia, Myeloid	34
Leukemia, Myeloid, Acute	33
Precursor Cell Lymphoblastic Leukemia-Lymphoma	20

Clinical Trial Locations for Cytosar-u

Trials by Country

Trials by Country for Cytosar-u
Location	Trials
United States	102
Italy	24
Puerto Rico	1
Iran, Islamic Republic of	1
China	1

Trials by US State

Trials by US State for Cytosar-u
Location	Trials
Texas	33
Washington	7
Ohio	4
California	3
Oregon	3

Clinical Trial Progress for Cytosar-u

Clinical Trial Phase

Clinical Trial Phase for Cytosar-u
Clinical Trial Phase	Trials
Phase 3	7
Phase 2/Phase 3	3
Phase 2	29

Clinical Trial Status

Clinical Trial Status for Cytosar-u
Clinical Trial Phase	Trials
Not yet recruiting	38
Completed	14
Recruiting	13

Clinical Trial Sponsors for Cytosar-u

Sponsor Name

Sponsor Name for Cytosar-u
Sponsor	Trials
National Cancer Institute (NCI)	42
M.D. Anderson Cancer Center	32
Children's Oncology Group	5

Sponsor Type

Sponsor Type for Cytosar-u
Sponsor	Trials
Other	61
NIH	42
Industry	21